BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32629816)

  • 1. Inhibition of Ovarian Cancer Cell Spheroid Formation by Synthetic Peptides Derived from Nectin-4.
    Boylan KLM; Manion RD; Shah H; Skubitz KM; Skubitz APN
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32629816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate.
    Boylan KL; Buchanan PC; Manion RD; Shukla DM; Braumberger K; Bruggemeyer C; Skubitz AP
    Oncotarget; 2017 Feb; 8(6):9717-9738. PubMed ID: 28038455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids.
    Rafehi S; Ramos Valdes Y; Bertrand M; McGee J; Préfontaine M; Sugimoto A; DiMattia GE; Shepherd TG
    Endocr Relat Cancer; 2016 Mar; 23(3):147-59. PubMed ID: 26647384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta 1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids.
    Casey RC; Burleson KM; Skubitz KM; Pambuccian SE; Oegema TR; Ruff LE; Skubitz AP
    Am J Pathol; 2001 Dec; 159(6):2071-80. PubMed ID: 11733357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype.
    Sodek KL; Ringuette MJ; Brown TJ
    Int J Cancer; 2009 May; 124(9):2060-70. PubMed ID: 19132753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BMP signalling controls the malignant potential of ascites-derived human epithelial ovarian cancer spheroids via AKT kinase activation.
    Peart TM; Correa RJ; Valdes YR; Dimattia GE; Shepherd TG
    Clin Exp Metastasis; 2012 Apr; 29(4):293-313. PubMed ID: 22249415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Claudin 4 Is differentially expressed between ovarian cancer subtypes and plays a role in spheroid formation.
    Boylan KL; Misemer B; De Rycke MS; Andersen JD; Harrington KM; Kalloger SE; Gilks CB; Pambuccian SE; Skubitz AP
    Int J Mol Sci; 2011 Feb; 12(2):1334-58. PubMed ID: 21541062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of size and shape of the ovarian cancer spheroids on the drug resistance and migration.
    Gunay G; Kirit HA; Kamatar A; Baghdasaryan O; Hamsici S; Acar H
    Gynecol Oncol; 2020 Nov; 159(2):563-572. PubMed ID: 32958270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions.
    Matte I; Legault CM; Garde-Granger P; Laplante C; Bessette P; Rancourt C; Piché A
    Clin Exp Metastasis; 2016 Dec; 33(8):839-852. PubMed ID: 27612856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers.
    Burleson KM; Casey RC; Skubitz KM; Pambuccian SE; Oegema TR; Skubitz AP
    Gynecol Oncol; 2004 Apr; 93(1):170-81. PubMed ID: 15047232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An mDia2/ROCK signaling axis regulates invasive egress from epithelial ovarian cancer spheroids.
    Pettee KM; Dvorak KM; Nestor-Kalinoski AL; Eisenmann KM
    PLoS One; 2014; 9(2):e90371. PubMed ID: 24587343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laminin-1-derived scrambled peptide AG73T disaggregates laminin-1-induced ovarian cancer cell spheroids and improves the efficacy of cisplatin.
    Yoshida Y; Kurokawa T; Nishikawa Y; Orisa M; Kleinman HK; Kotsuji F
    Int J Oncol; 2008 Mar; 32(3):673-81. PubMed ID: 18292945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nectin-2 in ovarian cancer: How is it expressed and what might be its functional role?
    Bekes I; Löb S; Holzheu I; Janni W; Baumann L; Wöckel A; Wulff C
    Cancer Sci; 2019 Jun; 110(6):1872-1882. PubMed ID: 30843637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.
    Frankel A; Man S; Elliott P; Adams J; Kerbel RS
    Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer.
    Puiffe ML; Le Page C; Filali-Mouhim A; Zietarska M; Ouellet V; Tonin PN; Chevrette M; Provencher DM; Mes-Masson AM
    Neoplasia; 2007 Oct; 9(10):820-9. PubMed ID: 17971902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SMYD3 promotes implant metastasis of ovarian cancer via H3K4 trimethylation of integrin promoters.
    Lyu T; Jiang Y; Jia N; Che X; Li Q; Yu Y; Hua K; Bast RC; Feng W
    Int J Cancer; 2020 Mar; 146(6):1553-1567. PubMed ID: 31503345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMIFH2-mediated mDia formin functional inhibition potentiates chemotherapeutic targeting of human ovarian cancer spheroids.
    Ziske MA; Pettee KM; Khaing M; Rubinic K; Eisenmann KM
    Biochem Biophys Res Commun; 2016 Mar; 472(1):33-9. PubMed ID: 26898799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of stable small cell number three-dimensional ovarian cancer spheroids using hanging drop arrays for preclinical drug sensitivity assays.
    Raghavan S; Ward MR; Rowley KR; Wold RM; Takayama S; Buckanovich RJ; Mehta G
    Gynecol Oncol; 2015 Jul; 138(1):181-9. PubMed ID: 25913133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17.
    Buchanan PC; Boylan KLM; Walcheck B; Heinze R; Geller MA; Argenta PA; Skubitz APN
    J Biol Chem; 2017 Apr; 292(15):6339-6351. PubMed ID: 28232483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and characteristics of an E-cadherin-related three-dimensional suspension growth model of ovarian cancer.
    Xu S; Yang Y; Dong L; Qiu W; Yang L; Wang X; Liu L
    Sci Rep; 2014 Jul; 4():5646. PubMed ID: 25008268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.